Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
about
The pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study.Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice.Pharmacovigilance in Italy: An overviewAnnual report on adverse events related with vaccines use in Calabria (Italy): 2012.Adjuvanted influenza vaccines.Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer.New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs).No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region.Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance.The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country.Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy.Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012.Bisphosphonate-related osteonecrosis of the jaw: an Italian post-marketing surveillance analysis.Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation.Italian Immunization Goals: A Political or Scientific Heated Debate?Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy
P2860
Q30359671-FCE50D35-9B46-4CFC-A239-34A8D22CEFBAQ30361076-1DE21556-1794-4077-905D-A27E853CCFB0Q30424161-BABC96F6-68D5-42BD-9A4E-D4C5DC8E71A2Q34329446-C04FE297-3B43-40F3-9CA8-C1849E92B722Q37369630-0A1FFCC6-BF6C-46D3-B092-E1D1C9C6D09DQ37369663-1F68F0A0-1565-4DC6-9479-3DDA9ED753C8Q37976540-E0B781DA-273A-48D8-888F-072795C73843Q38045917-236A98CC-332D-4431-B13A-C9D79200EC39Q38199737-9CF6A202-B5AC-4FF2-BF4A-7EB4CAD052A7Q39016874-CB123139-3830-4B34-875A-2CC62072652BQ39162849-249993AE-D19B-49F0-A157-DCC3106C7830Q41601832-F57A1C92-7E57-40F7-AD2C-6697933FD33EQ43171845-1023711C-3EE3-4368-A544-8BE0451AC1EDQ44041568-B1B73B91-AEF4-400A-B8CB-6A7485D06945Q44280390-57FAC9D0-AAD4-4999-A913-2A00E46D1527Q45786168-729C2359-2FD9-41C7-A5FA-2B9D5609C2CBQ48223183-9172820D-F9EF-4CB2-83EC-52AAF2256820Q55100726-191DE34E-0402-47FD-A2B7-0BA6EB075D9CQ58764780-D88714B6-FB6A-48D0-A97C-A89452F469F3
P2860
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@ast
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@en
type
label
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@ast
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@en
prefLabel
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@ast
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@en
P2093
P1433
P1476
Italian post-marketing surveil ...... -adjuvanted H1N1v vaccination.
@en
P2093
Benedetta Ianniello
Elisabetta Parretta
Fernanda Ferrazin
Francesco Rossi
P304
P356
10.1016/J.VACCINE.2011.02.097
P407
P577
2011-03-12T00:00:00Z